Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11699414 | 0.83 | DPP4 (0.42) | CYP3A4MAPK1HSD17B10ALDH1A1TDP1 | |
| SCHEMBL335595 | 0.81 | CYP3A4 (0.48) | CYP3A4MAPK1HSD17B10ALDH1A1TDP1 | |
| SCHEMBL29566553 | 0.81 | CYP3A4 (0.48) | CYP3A4MAPK1HSD17B10ALDH1A1TDP1 | |
| Water SCHEMBL29243256 | 0.79 | CYP3A4 (0.46) | CYP3A4MAPK1HSD17B10ALDH1A1TDP1 | |
| SCHEMBL3246842 | 0.79 | CYP3A4 (0.59) | CYP3A4MAPK1HSD17B10ALDH1A1TDP1 | |
| SCHEMBL48082 | 0.79 | ALDH1A1 (0.43) | CYP3A4MAPK1HSD17B10ALDH1A1TDP1 | |
| SCHEMBL3790032 | 0.79 | CYP3A4 (0.46) | CYP3A4MAPK1HSD17B10ALDH1A1TDP1 | |
| SCHEMBL3034116 | 0.79 | CES1 (0.41) | CYP3A4MAPK1HSD17B10ALDH1A1TDP1 | |
| SCHEMBL3708636 | 0.77 | TRPA1 (0.46) | MAPK1HSD17B10ALDH1A1TDP1TRPA1 | |
| SCHEMBL31290749 | 0.77 | TRPA1 (0.46) | MAPK1HSD17B10ALDH1A1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101070198-A | Method for thoroughly degradating chloroguaiacol pulp bleaching waste-water | GUANGXI NATIONNALITY UNIV (CN) | 2007-11-14 | — | — | CN | claimed |
| WO-2020132603-A2 | SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2020-06-25 | — | — | WO | disclosed |
| US-7820862-B2 | Ligand, method for producing the same, and catalyst using the ligand | THE UNIVERSITY OF TOKYO (JP) | 2010-10-26 | — | — | US | disclosed |
| US-20090023579-A1 | Ligand, Method for Producing the Same, and Catalyst Using the Ligand | THE UNIVERSITY OF TOKYO (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1995250-A1 | LIGAND, METHOD FOR PRODUCING THE SAME, AND CATALYST USING THE LIGAND | The University of Tokyo (JP) | 2008-11-26 | — | — | EP | disclosed |
| CN-101070198-A | Method for thoroughly degradating chloroguaiacol pulp bleaching waste-water | GUANGXI NATIONNALITY UNIV (CN) | 2007-11-14 | — | — | CN | disclosed |
| US-6759435-B1 | SUCH AS METHYL-(1-(2-(1-PHENYL-ETHYL)-PHENYL)-ETHYL)-AMINE; SEROTONIN REUPTAKE INHIBITORS | A.P. Group Inc. | 2004-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023579-A1 | Ligand, Method for Producing the Same, and Catalyst Using the Ligand | CHRM1, CHRM2, B3GNT2 | CYP3A4 431/4885MAPK1 3186/4885HSD17B10 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.